CooperVision (NYSE:COO) announced that it acquired customized orthokeratology contact lens manufacturer and distributor GP Specialists for an undisclosed amount. San Ramon, Calif.-based CooperVision said in a news release that the acquisition expands its specialty eye care business and its leadership in addressing myopia. GP Specialists’ portfolio of ortho-k lenses include the iSee design and the OK-GOV […]
Optical/Ophthalmic
eSight launches next-gen vision aid
eSight announced today that it launched its eSight 4 wearable assistive device for enhancing vision in those with eye disease and disorders. Toronto-based eSight’s latest vision aid technology includes greater visual clarity and a more versatile hardware design with cloud-based capabilities and mobile apps for people with diseases and disorders that lead to low vision […]
NovaSight raises $8m for lazy eye treatment device
Israeli startup NovaSight announced today that it has raised $8 million in a Series A round meant to support a large multi-center randomized pivotal study of its lazy eye treatment device. Study results will support potential FDA 510(k) clearance for the device. The money will also support development of future eye care products such as […]
WaveFront Dynamics opens HQ in New Mexico
Ophthalmic medical device startup WaveFront Dynamics has opened a 9,800 ft2 headquarters in Albuquerque, N.M. WaveFront Dynamics CEO Dan Neal in a news release today described the one-year-old company as “not a typical seed-stage startup.” The company has a fully staffed R&D team with state-of-the-art optical labs, optometry lane, and machine shops in place to […]
Staar Surgical launches presbyopia correcting lens
Staar Surgical (NSDQ:STAA) announced today that it received CE Mark approval for its EVO Viva presbyiopia-correcting implantable Collamer lens (ICL). Lake Forest, Calif.-based Staar Surgical is launching the EVO Viva through select doctors in Spain, Germany and Belgium, initially, with broader availability set to follow across Europe and other markets recognizing the CE Mark, according to […]
VisionCare names new CEO
Visual prosthetic device developer VisionCare announced today that Thomas Ruggia has been appointed as its new CEO, effective today. Saratoga, Calif.-based VisionCare’s previous CEO and executive chairman of the board, Wolfgang Tolle, left the company to focus on new opportunities, according to a news release. “We’re thrilled to welcome Tom to VisionCare,” VisionCare CEO Richard […]
VyCor Medical, NovaVision sign licensing agreement
Vycor Medical (OTC:VYCO) announced that its wholly-0wned subsidiary NovaVision entered into a licensing agreement with HelferApp GmbH. The exclusive licensing agreement gives HelferApp the exclusive rights for NovaVision’s diagnostic products and therapies provided directly to patients and medical professionals in Germany, Austria and Switzerland, according to a news release. Vycor previously said in May that it […]
Support grows for return of medtech reps to hospitals
Twenty-six more medical and surgical societies and healthcare associations have endorsed guidelines for the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic. The guidance, released in May by AdvaMed, the Association of periOperative Registered Nurses (AORN) and the American Hospital Association (AHA), builds on the April 17 joint statement by AHA, […]
Glaukos announces $200m offering
Glaukos (NYSE:GKOS) announced today that it intends to offer convertible senior notes worth $200 million in a private offering. San Clemente, Calif.-based Glaukos is offering the notes, due in 2027, only to qualified institutional buyers with a 13-day option for initial purchasers to purchase up to an additional $30 million in notes, according to a news […]
SightGlass Vision wins CE Mark for eyeglass lenses
SightGlass Vision announced today that it received CE Mark approval in Europe for its eyeglasses for slowing myopia progression in children. Palo Alto, Calif.-based SightGlass Vision touts its novel diffusion optics technology (DOT) spectacle lens products as the first of its kind to show success in a multi-center, randomized, controlled clinical trial to include options […]
Ocular Therapeutix commences public offering
Ocular Therapeutix (NSDQ:OCUL) announced that it commenced an underwritten public offering of an undisclosed amount of its common stock. The Bedford, Mass.-based eye condition therapy developer filed with the SEC to confirm the offering with the shares at a par value of $0.0001 per share. The common stock at market close on May 18 prior to […]
